Page 195 - Read Online

regeneration. Cell Growth Differ 1995;6:417-27. miR-122 level for de novo HBV infection in culture. Virology
285. Koike K, Moriya K, Yotsuyanagi H, Shintani Y, Fujie H, Tsutsumi 2014;448:247-54.
T, Kimura S. Compensatory apoptosis in preneoplastic liver of a 302. Thornton JE, Gregory RI. How does Lin28 let-7 control development
transgenic mouse model for viral hepatocarcinogenesis. Cancer Lett and disease? Trends Cell Biol 2012;22:474-82.
1998;134:181-6. 303. Guo H, Liu H, Mitchelson K, Rao H, Luo M, Xie L, Sun Y, Zhang
286. Jopling CL, Yi M, Lancaster AM, Lemon SM, Sarnow P. Modulation L, Lu Y, Liu R, Ren A, Liu S, Zhou S, Zhu J, Zhou Y, Huang A, Wei
of hepatitis C virus RNA abundance by a liver-specific MicroRNA. L, Guo Y, Cheng J. MicroRNAs-372/373 promote the expression
Science 2005;309:1577-81. of hepatitis B virus through the targeting of nuclear factor I/B.
287. Henke JI, Goergen D, Zheng J, Song Y, Schuttler CG, Fehr C, Hepatology 2011;54:808-19.
Junemann C, Niepmann M. MicroRNA-122 stimulates translation 304. Jin J, Tang S, Xia L, Du R, Xie H, Song J, Fan R, Bi Q, Chen Z, Yang
of hepatitis C virus RNA. EMBO J 2008;27:3300-10. G, Liu J, Shi Y, Fan D. MicroRNA-501 promotes HBV replication
288. Kitab B, Alj HS, Ezzikouri S, Benjelloun S. MicroRNAs as by targeting HBXIP. Biochem Biophys Res Commun 2013;430:1228-
important players in host-hepatitis b virus interactions. J Clin Transl 33.
Hepatol 2015;3:149-61. 305. Wang Y, Jiang L, Ji X, Yang B, Zhang Y, Fu XD. Hepatitis B viral
289. Hou J, Lin L, Zhou W, Wang Z, Ding G, Dong Q, Qin L, Wu X, RNA directly mediates down-regulation of the tumor suppressor
Zheng Y, Yang Y, Tian W, Zhang Q, Wang C,Zhang Q, Zhuang SM, microRNA miR-15a/miR-16-1 in hepatocytes. J Biol Chem
Zheng L, Liang A, Tao W, Cao X. Identification of miRNomes in 2013;288:18484-93.
human liver and hepatocellular carcinoma reveals miR-199a/b- 306. Wang Y, Lu Y, Toh ST, Sung WK, Tan P, Chow P, Chung AY, Jooi
3p as therapeutic target for hepatocellular carcinoma. Cancer cell LL, Lee CG. Lethal-7 is down-regulated by the hepatitis B virus x
2011;19:232-43. protein and targets signal transducer and activator of transcription 3.
290. Lagos-Quintana M, Rauhut R, Yalcin A, Meyer J, Lendeckel W, J Hepatol 2010;53:57-66.
Tuschl T. Identification of tissue-specific microRNAs from mouse. 307. Zhang ZZ, Liu X, Wang DQ, Teng MK, Niu LW, Huang AL, Liang
Curr Biol 2002;12:735-9. Z. Hepatitis B virus and hepatocellular carcinoma at the miRNA
291. Chen Y, Shen A, Rider PJ, Yu Y, Wu K, Mu Y, Hao Q, Liu Y, level. World J Gastroenterol 2011;17:3353-8.
Gong H, Zhu Y, Liu F, Wu J. A liver-specific microRNA binds 308. Dai X, Zhang W, Zhang H, Sun S, Yu H, Guo Y, Kou Z, Zhao G, Du
to a highly conserved RNA sequence of hepatitis B virus and L, Jiang S, Zhang J, Li J, Zhou Y. Modulation of HBV replication
negatively regulates viral gene expression and replication. FASEB by microRNA-15b through targeting hepatocyte nuclear factor 1α.
J 2011;25:4511-21. Nucleic Acids Res 2014;42:6578-90.
292. Li C, Wang Y, Wang S, Wu B, Hao J, Fan H, Ju Y, Ding Y, Chen L, 309. Gramantieri L, Fornari F, Callegari E, Sabbioni S, Lanza G,
Chu X, Liu W, Ye X, Meng S. Hepatitis B virus mRNA-mediated Croce CM, Bolondi L, Negrini M. MicroRNA involvement in
miR-122 inhibition upregulates PTTG1-binding protein, which hepatocellular carcinoma. J Cell Mol Med 2008;12:2189-204.
promotes hepatocellular carcinoma tumor growth and cell invasion. 310. Liu Y, Zhao JJ, Wang CM, Li MY, Han P, Wang L, Cheng YQ,
J Virol 2013;87:2193-205. Zoulim F, Ma X, Xu DP. Altered expression profiles of microRNAs
293. Qiu L, Fan H, Jin W, Zhao B, Wang Y, Ju Y, Chen L, Chen Y, Duan in a stable hepatitis B virus-expressing cell line. Chin Med J
Z, Meng S. MiR-122-induced down-regulation of HO-1 negatively 2009;122:10-4.
affects miR-122-mediated suppression of HBV. Biochem Biophys 311. Wu CS, Yen CJ, Chou RH, Chen JN, Huang WC, Wu CY, Yu YL.
Res Commun 2010;398:771-7. Downregulation of microRNA-15b by hepatitis B virus X enhances
294. Fornari F, Gramantieri L, Giovannini C, Veronese A, Ferracin hepatocellular carcinoma proliferation via fucosyltransferase
M, Sabbioni S, Calin GA, Grazi GL, Croce CM, Tavolari S, 2-induced Globo H expression. Int J Cancer 2014;134:1638-47.
Chieco P, Negrini M, Bolondi L. MiR-122/cyclin G1 interaction 312. Wu G, Yu F, Xiao Z, Xu K, Xu J, Tang W, Wang J, Song E. Hepatitis
modulates p53 activity and affects doxorubicin sensitivity of human B virus X protein downregulates expression of the miR-16 family
hepatocarcinoma cells. Cancer Res 2009;69:5761-7. in malignant hepatocytes in vitro. Br J Cancer 2011;105:146-53.
295. Gramantieri L, Ferracin M, Fornari F, Veronese A, Sabbioni S, 313. Coppola N, Potenza N, Pisaturo M, Mosca N, Tonziello G, Signoriello
Liu CG, Calin GA, Giovannini C, Ferrazzi E, Grazi GL, Croce G, Messina V, Sagnelli C, Russo A, Sagnelli E. Liver microRNA
CM, Bolondi L, Negrini M. Cyclin G1 is a target of miR-122a, a hsa-miR-125a-5p in HBV chronic infection: correlation with HBV
microRNA frequently down-regulated in human hepatocellular replication and disease progression. PloS One 2013;8:e65336.
carcinoma. Cancer Res 2007;67:6092-9. 314. Mosca N, Castiello F, Coppola N, Trotta MC, Sagnelli C, Pisaturo
296. Fan CG, Wang CM, Tian C, Wang Y, Li L, Sun WS, Li RF, Liu YG. M, Sagnelli E, Russo A, Potenza N. Functional interplay between
MiR-122 inhibits viral replication and cell proliferation in hepatitis hepatitis B virus X protein and human miR-125a in HBV infection.
B virus-related hepatocellular carcinoma and targets NDRG3. Biochem Biophys Res Commun 2014;449:141-5.
Oncol Rep 2011;26:1281-6. 315. Jung YJ, Kim JW, Park SJ, Min BY, Jang ES, Kim NY, Jeong SH,
297. Peng F, Xiao X, Jiang Y, Luo K, Tian Y, Peng M, Zhang M, Xu Shin CM, Lee SH, Park YS, Hwang JH, Kim N, Lee DH. C-Myc-
Y, Gong G. HBx down-regulated Gld2 plays a critical role in hbv- mediated overexpression of miR-17-92 suppresses replication of
related dysregulation of miR-122. PloS One 2014;9:e92998. hepatitis B virus in human hepatoma cells. J Med Virol 2013;85:969-
298. Song K, Han C, Zhang J, Lu D, Dash S, Feitelson M, Lim K, Wu T. 78.
Epigenetic regulation of microRNA-122 by peroxisome proliferator 316. Cheng PN, Liu WC, Tsai HW, Wu IC, Chang TT, Young KC.
activated receptor-gamma and hepatitis b virus X protein in Association of intrahepatic cccDNA reduction with the improvement
hepatocellular carcinoma cells. Hepatology 2013;58:1681-92. of liver histology in chronic hepatitis B patients receiving oral
299. Wang S, Qiu L, Yan X, Jin W, Wang Y, Chen L, Wu E, Ye X, antiviral agents. J Med Virol 2011;83:602-7.
Gao GF, Wang F, Chen Y, Duan Z, Meng S. Loss of microRNA 317. Ghany MG, Doo EC. Antiviral resistance and hepatitis B therapy.
122 expression in patients with hepatitis B enhances hepatitis B Hepatology 2009;49:S174-84.
virus replication through cyclin G(1) -modulated P53 activity. 318. Yang HC, Kao JH. Viral hepatitis. HBV cure--can we pin our hopes
Hepatology 2012;55:730-41. on immunotherapy? Nat Rev Gastroenterol Hepatol 2015;12:129-
300. Denzler R, Agarwal V, Stefano J, Bartel DP, Stoffel M. Assessing 31.
the ceRNA hypothesis with quantitative measurements of mirna and 319. Zoulim F. Antiviral therapy of chronic hepatitis B: can we clear
target abundance. Mol Cell 2014;54:766-76. the virus and prevent drug resistance? Antivir Chem Chemother
301. Xu G, Gao Z, He W, Ma Y, Feng X, Cai T, Lu F, Liu L, Li W. 2004;15:299-305.
MicroRNA expression in hepatitis B virus infected primary 320. Zoulim F. Emerging drugs for hepatitis B. Expert Opin Emerg Drugs
treeshrew hepatocytes and the independence of intracellular 2007;12:199-217.
186 Hepatoma Research | Volume 2 | July 1, 2016